Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Phys Occup Ther Pediatr ; 27(4): 43-65, 2007.
Article in English | MEDLINE | ID: mdl-18032149

ABSTRACT

This pilot study examined the feasibility of a 6-week group-based, task-related training program in children 6 to 14 years-old with spastic diplegia. Eight children were randomized to lower limb training and seven to an upper limb dexterity training program. There were no statistically significant differences in lower limb outcomes between children who received the lower limb training and children who received the upper limb dexterity training after completion of the interventions or at a 6-week follow-up. Children who received the upper limb training demonstrated a greater improvement on measures of manual dexterity compared with children who received the lower limb training program. Children who received the lower limb training demonstrated a trend toward walking a longer distance in 10 minutes immediately following intervention, that was not sustained at the 6-week follow-up. The group setting appeared to motivate the children and enhance their participation in the training programs. The pilot study provides data for the calculation of effect size and sample estimates for future studies.


Subject(s)
Cerebral Palsy/rehabilitation , Adolescent , Child , Feasibility Studies , Female , Group Processes , Humans , Male , Physical Therapy Modalities , Pilot Projects , Statistics, Nonparametric , Treatment Outcome
2.
Dev Med Child Neurol ; 45(10): 664-70, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14515937

ABSTRACT

The aim of this study was to determine the reliability and magnitude of error of three lower-limb clinical measures for children with cerebral palsy (CP): the Modified Ashworth Scale of Spasticity (MAS), passive range of movement (PROM) and the modified Tardieu scale (MTS). Six physiotherapists measured 11 females and seven males (mean age 6 years 4 months, SD 2 years 4 months; age range 2 years 4 months to 10 years) on two occasions using a repeated measures design, collecting all data over 6 days. The severity of CP spanned all five levels of the Gross Motor Function Classification System and all children demonstrated varying degrees of spasticity. Exclusion criteria included botulinum toxin injections, inhibitory plasters, and orthopaedic surgery within the 6 months before study entry. For PROM and the MTS interrater reliability was acceptable with an intraclass correlation coefficient of 0.7, but results for MAS were lower. Standard error of measurement for repeated measures of PROM and MTS was about five degrees, but 95% confidence interval ranges were considerably higher. Test-retest results varied widely, particularly for the MAS. These measurement tools should be used with caution when evaluating changes in young children with CP.


Subject(s)
Cerebral Palsy/physiopathology , Joints/physiopathology , Muscle, Skeletal/physiopathology , Severity of Illness Index , Cerebral Palsy/therapy , Child , Child, Preschool , Exercise Therapy , Female , Humans , Lower Extremity/physiopathology , Male , Posture/physiology , Range of Motion, Articular , Reproducibility of Results
3.
Dev Med Child Neurol ; 44(12): 820-7, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12455858

ABSTRACT

We evaluated gross motor function following botulinum toxin A (BTX-A) injections in the lower limbs of children with spastic cerebral palsy in a randomized clinical trial, using a cross-over design. Forty-nine children (24 males, 25 females, age range 22 to 80 months) were randomly allocated to two groups: group 1 received BTX-A and physiotherapy, and group 2 received physiotherapy alone for 6 months. At the end of this period, group 2 received BTX-A and physiotherapy and group 1 continued with physiotherapy alone. Assessment measures were the Gross Motor Function Measure (GMFM), the Vulpe Assessment Battery (VAB), joint range of movement, the Modified Ashworth Scale, and a parental questionnaire. Sustained gains in gross motor function were found in both groups of children but the only additional benefit found in group 1 was a significant increase in fine motor rating on the VAB. By contrast, parents rated the benefit of treatment highly. It is likely that assessment at 3 and 6 months post injection was too late to demonstrate peak gross motor function response and that changes in GMFM are not sustained over 6 months with a single dose. Further studies should investigate changes over shorter time periods and consider covariables such as BTX-A dosage, number of injection sites, and the role of repeated injections combined with other interventions such as casting.


Subject(s)
Botulinum Toxins, Type A/therapeutic use , Cerebral Palsy/physiopathology , Cerebral Palsy/therapy , Lower Extremity/physiopathology , Neuromuscular Agents/therapeutic use , Cerebral Palsy/diagnosis , Cerebral Palsy/drug therapy , Cross-Over Studies , Humans , Physical Therapy Modalities , Severity of Illness Index , Surveys and Questionnaires , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...